s6y
Company name or ticker
Search
Telomir Pharmaceuticals, Inc.
4
MacPherson Edward Clouston: Statement of changes in beneficial ownership of securities
Filed
Monday, July 27, 2026
Period
Apr 16, 2026
Accession number
0001493152-26-034811
Documents
4
4
On sec.gov
Filing index
All files
Complete submission text
SGML header